Louis Navellier Details The Big Day Coming for Cash Holders
The explosive rise of tech stocks we saw in 2020 is just the beginning...

"The Earnings Whisperer" Louis Navellier released a video detailing several key steps he believes every American should be taking right now.
Click here to view it.

RSLS Insider Trading (ReShape Lifesciences)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $140,003.00
Insider Selling (Last 12 Months): $1,588,865.40

ReShape Lifesciences Insider Trading History Chart

This chart shows the insider buying and selling history at ReShape Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ReShape Lifesciences Share Price & Price History

Current Price: $3.02
Price Change: Price Increase of +0.11 (3.78%)
As of 09/17/2021 01:00 AM ET

This chart shows the closing price history over time for RSLS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarketBeat's Top 5 Stock Picks - Just Released
MarketBeat has just released five new trading ideas, but Tesla, Apple, and Netflix didn't make the cut. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Now, MarketBeat thinks these five stocks may be even better buys.
View the Stocks Here

ReShape Lifesciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Barton P BandyCEOSell294,494$2.89$851,087.66View SEC Filing Icon  
9/10/2021Dan W GladneyDirectorSell200,000$2.99$598,000.00View SEC Filing Icon  
9/10/2021Thomas StankovichCFOSell48,366$2.89$139,777.74315,995View SEC Filing Icon  
8/30/2021Thomas StankovichCFOBuy15,000$3.43$51,450.0032,613View SEC Filing Icon  
8/20/2021Thomas StankovichCFOBuy15,000$3.22$48,300.0017,613View SEC Filing Icon  
12/4/2020Armistice Capital Master FundMajor ShareholderBuy6,400$4.16$26,624.00
9/22/2020Armistice Capital Master FundMajor ShareholderBuy3,300$4.13$13,629.00
8/20/2020Armistice Capital Master FundMajor ShareholderBuy9,998$3.13$31,293.74
1/29/2020Armistice Capital Master FundMajor ShareholderBuy3,000$8.00$24,000.00
12/20/2019Armistice Capital Master FundMajor ShareholderBuy12,048$5.00$60,240.00
12/16/2019Armistice Capital Master FundMajor ShareholderBuy3,000$5.50$16,500.00
12/11/2019Armistice Capital Master FundMajor ShareholderBuy2,523$5.45$13,750.35
9/17/2019Armistice Capital Master FundMajor ShareholderBuy396,072$0.05$19,803.60
8/29/2019Armistice Capital Master FundMajor ShareholderBuy200,000$0.07$14,000.00View SEC Filing Icon  
8/8/2019Armistice Capital Master FundMajor ShareholderBuy350,000$0.07$24,500.00View SEC Filing Icon  
7/26/2019Armistice Capital Master FundMajor ShareholderBuy500,000$0.08$40,000.00View SEC Filing Icon  
1/30/2019Sabby Management, LlcMajor ShareholderBuy60,200$0.28$16,856.00View SEC Filing Icon  
1/25/2019Sabby Management, LlcMajor ShareholderBuy21,785$0.27$5,881.95View SEC Filing Icon  
1/22/2019Sabby Management, LlcMajor ShareholderBuy5,766$0.28$1,614.48View SEC Filing Icon  
1/18/2019Sabby Management, LlcMajor ShareholderBuy24,386$0.28$6,828.08View SEC Filing Icon  
1/16/2019Sabby Management, LlcMajor ShareholderBuy194,421$0.24$46,661.04View SEC Filing Icon  
See Full Table
Insider Trading at ReShape Lifesciences?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ReShape Lifesciences and related companies.

SEC Filings (Institutional Ownership Changes) for ReShape Lifesciences (OTCMKTS:RSLS)

66.58% of ReShape Lifesciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RSLS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ReShape Lifesciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/17/2021Armistice Capital LLC816,527$4.08M0.1%N/A24.447%Search for SEC Filing on Google Icon
8/16/2021State Street Corp109,999$0.55M0.0%N/A3.293%Search for SEC Filing on Google Icon
8/13/2021Alpine Global Management LLC17,000$85K0.0%N/A0.509%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC23,277$0.12M0.0%N/A0.697%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.51,120$0.26M0.0%N/A1.531%Search for SEC Filing on Google Icon
11/13/2018Renaissance Technologies LLC2,287,729$0.10M0.0%N/A3,812.882%Search for SEC Filing on Google Icon
8/13/2018International Biotechnology Trust PLC52,546$0.12M0.0%-93.3%0.824%Search for SEC Filing on Google Icon
2/15/2018Anson Funds Management LP219,016$0.32M0.2%N/A0.731%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ReShape Lifesciences logo
ReShape Lifesciences, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShapeCare and Diabetes Bloc-Stim Neuromodulation Device. The company is headquartered in San Clemente, CA.
Read More on ReShape Lifesciences

Today's Range

Now: $3.02
Low: $2.91
High: $3.03

50 Day Range

MA: $3.55
Low: $2.85
High: $4.59

52 Week Range

Now: $3.02
Low: $2.16
High: $32.31


1,097,470 shs

Average Volume

1,221,043 shs

Market Capitalization

$47.84 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of ReShape Lifesciences?

ReShape Lifesciences' top insider shareholders include:
  1. Thomas Stankovich (CFO)
  2. Armistice Capital Master Fund (Major Shareholder)
  3. Armistice Capital, Llc (Major Shareholder)
  4. Barton P Bandy (CEO)
  5. Dan W Gladney (Director)

Who are the major institutional investors of ReShape Lifesciences?

ReShape Lifesciences' top institutional shareholders include:
  1. Armistice Capital LLC — 24.45%
  2. State Street Corp — 3.29%
  3. Vanguard Group Inc. — 1.53%
  4. Geode Capital Management LLC — 0.70%
  5. Alpine Global Management LLC — 0.51%

Which major investors are buying ReShape Lifesciences stock?

In the last quarter, RSLS stock was acquired by institutional investors including:
  1. Armistice Capital LLC
  2. State Street Corp
  3. Vanguard Group Inc.
  4. Geode Capital Management LLC
  5. Alpine Global Management LLC
During the previous year, these company insiders have bought ReShape Lifesciences stock:
  1. Thomas Stankovich (CFO)
  2. Armistice Capital Master Fund (Major Shareholder)
The “Tech Royalty” Retirement Plan Can Help You Live Like Royalty
For the first time ever, a new type of tech investment allows you to collect ongoing income. One former Wall Street insider calls them, “Tech Royalties.”

And new “Tech Royalty” savings accounts allow you to collect as much as 8%... 12%... and even 17% or more.
Find out why “Tech Royalties” may be the best asse